Interspecies allometric scaling: Prediction of clearance in large animal species: Part II: Mathematical considerations

Journal of Veterinary Pharmacology and Therapeutics

Volumn 29, Issue 5, 2006, Pages 425-432

  Martinez, M ^a   Mahmood, I ^b   Hunter, R P ^c  

^a Center for Veterinary Medicine   (United States)

^b Center for Drug Evaluation and Research   (United States)

^c ELANCO ANIMAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ALLOMETRY; ARTICLE; BODY SIZE; BODY WEIGHT; DRUG CLEARANCE; HUMAN VERSUS ANIMAL COMPARISON; MATHEMATICAL ANALYSIS; OPTIMAL DRUG DOSE; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SPECIES COMPARISON;

ANIMALS; BODY WEIGHT; METABOLIC CLEARANCE RATE; ORGAN SIZE; REGRESSION ANALYSIS; SPECIES SPECIFICITY;

ANIMALIA; CAMELIDAE; ELEPHANTIDAE;

EID: 33748372738     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2006.00787.x     Document Type: Article

References (15)

1. Boxenbaum, H. (1982) Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics, 10, 201-227.
2. Boxenbaum, H. & DiLea, C. (1995) First-time-in-human dose selection: allometric thoughts and perspectives. Journal of Clinical Pharmacology, 35, 957-966.
3. Bregante, M.A., Saez, P., Aramayona, J.J., Fraile, L., Garcia, M.A. & Solans, C. (1999) Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep and cows. American Journal of Veterinary Research, 60, 1111-1116.
4. Cox, S.K., Cottrell, M.B., Smith, L., Papich, M.G., Frazier, D.L. & Bartges, J. (2004) Allometric analysis of ciprofloxacin and enrofloxacin pharmacokinetics. Journal of Veterinary Pharmacology and Therapeutics, 27, 139-146.
5. Craigmill, A.L. & Cortright, K.A. (2002) Interspecies considerations in the evaluation of human food safety for veterinary drugs. AAPS PharmSci 4(4), article 34.
6. Draper, N.R. & Smith, H. (1981) Applied Regression Analysis, 2nd edn. John Riley and Sons, New York.
7. Hu, T.M. & Hayton, W.L. (2001) Allometric scaling of xenobiotic CL: uncertainty versus universality. AAPS Pharm Sci, 3(4), article 29.
8. Hunter, R.P. & Isaza, R. (2002) Zoological pharmacology: current status, issues, and potential. Advanced Drug Delivery Reviews, 54, 787-793.
9. Isaza, R. & Hunter, R.P. (2004) Drug delivery to captive Asian elephants - treating goliath. Current Drug Delivery, 1, 291-298.
10. Mahmood, I. & Balian, J.D. (1996) Interspecies scaling: predicting clearance of drugs in humans. Three different approaches. Xenobiotica, 26, 887-895.
11. Mahmood, I., Martinez, M. & Hunter, R.P. (2006) Interspecies allometric scaling: prediction of clearance in large animals (Part I). Journal of Veterinary Pharmacology and Therapeutics, 29, 415-423.
12. Mordenti, J. (1986) Man versus beast: pharmacokinetic scaling in mammals. Journal of Pharmaceutical Sciences, 75, 1028-1040.
13. Mordenti, J., Chen, S.A., Moore, J.A., Ferraiolo, B.L. & Green, J.D. (1991) Interspecies scaling of CL and volume of distribution data for five therapeutic proteins. Pharmaceutical Research, 8, 1351-1359.
14. Riviere, J.E., Martin-Jimenez, T., Sundlof, S.F. & Craigmill, A.L. (1997) Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species. Journal of Veterinary Pharmacology and Therapeutics, 20, 453-463.
15. Spector, W.S. (1956) Handbook of Biological Data, pp. 163-164. W. B. Saunders Co., Philadelphia.